CNSL.L

Cambridge Nutritional Sciences
Cambridge Nutrition. - Scientific Educational Webinar and Industry Event
22nd January 2024, 07:00
TwitterFacebookLinkedIn
To continue viewing RNS, please confirm that you are a Private Investor*

* A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:

  1. Obtains access to the information in a personal capacity;
  2. Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
  3. Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
  4. Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
  5. Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
  6. Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
RNS Number : 3499A
Cambridge Nutritional Sciences PLC
22 January 2024
 

 

Cambridge Nutritional Sciences plc

("CNS" or the "Company")

 

Q1 Scientific Educational Programme Webinar and Industry Event

 

·    Company's next educational webinar on food sensitivity to take place later this month

·    CNS to exhibit at prominent gut health event in Birmingham in March

 

CNS (AIM: CNSL), the specialist medical diagnostics company focused on promoting a personalised and functional approach to health and nutrition, announces two events happening in Q1 2024. The first is a proprietary CNSLab webinar "Food Sensitivity in Clinical Practice", and the second is CNS's attendance at the British Association for Nutrition and Lifestyle Medicine ('BANT') Gut Health and Functional Testing event.

 

The webinar forms part of the Company's ongoing Scientific Education Programme, a key initiative which enables CNS to collaborate with a number of global and UK-based key opinion leaders in the nutritional science field. The BANT event, which typically attracts 225 to 550 attendees, will provide CNS with the opportunity to foster even closer relationships with nutritional practitioners and healthcare professionals.

 

CNS Educational Webinar: "Food Sensitivity in Clinical Practice"

 

This Continual Professional Development ('CPD') accredited webinar is exclusively for healthcare professionals and will explore the important terminology that distinguishes IgE food allergy from IgG food sensitivity and food intolerances. It takes place on Tuesday 30 January at 11am GMT and will be hosted by guest speaker and BANT member Kirsty Baxter, a CNHC Registered Nutritional Therapist with nearly eight years of clinical practice who holds a Masters in Advanced Nutrition. Kirsty completed training in Applying Functional Medicine in Clinical Practice ('IFM') and is a published researcher. Her specialisms include metabolic conditions: including diabetes, insulin resistance, metabolic syndrome, PCOS and weight loss and she works extensively with Irritable Bowel Syndrome and Food Sensitivities Testing.

 

BANT "Gut Health and Functional Testing"

 

CNS will exhibit at the event which is taking place at The University of Birmingham, UK, on 1-2 March. BANT is the leading professional body for Registered Nutritional Therapy Practitioners in one-to-one clinical practice and a self-regulator for BANT Registered Nutritionists®. The two-day event on nutrition and lifestyle medicine approaches is focused on gut health, with extensive coverage of the current availability and value of functional testing. Across the two days, speakers will cover the latest research around gut dysbiosis - symptoms, causes, assessments, and interventions including dietary, lifestyle and nutraceuticals. As a sponsor, CNS will also take part in a Facebook Live event within a four-week period after the conclusion of the event; this will be available to BANT members.

 

 

Commenting, Jag Grewal, Chief Executive Officer, said:

 

"We are delighted to be delivering our next educational webinar in January. CNS remains committed to delivering a comprehensive scientific education programme to help build awareness and promote knowledge sharing among healthcare practitioners. It remains a key initiative that enables the Company to collaborate with a number of global and UK-based key opinion leaders in the nutritional science field.

 

"We are also excited to participate in and sponsor the BANT gut health and functional testing event. Not only is the topic hugely pertinent for CNS, the reach BANT has through its broad member network allows CNS to build relationships and engage with relevant practitioners - a vital component of the Company's approach."

 

 

Contacts: 

Cambridge Nutritional Sciences PLC           

www.cnsplc.com

Jag Grewal, Chief Executive Officer                 

via Walbrook PR



Cavendish Capital Markets Limited    

Tel: 020 7220 0500

Geoff Nash / Edward Whiley / George Dollemore (Corporate Finance)


Nigel Birks / Harriet Ward (ECM)




Walbrook PR Limited

Tel: 020 7933 8780 or omega@walbrookpr.com

Paul McManus / Charlotte Edgar

Mob: 07980 541 893 / Mob: 07884 664 686 /

Sam Allen

Mob: 07502 558 258

 

 


About Cambridge Nutritional Sciences plc

Cambridge Nutritional Sciences plc (AIM: CNSL) is a specialist medical diagnostics company focused on industry-leading Health and Nutrition products.

 

About BANT and BANT Members

The British Association for Nutrition and Lifestyle Medicine ('BANT') is the largest non-profit professional body representing c. 3,500 nutrition practitioners, giving the public the confidence to work with professionals that are trained in application of nutrition and lifestyle sciences to support their health and wellbeing.

 

For more information visit: British Association For Nutrition And Lifestyle Medicine - BANT

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRABLMATMTABBLI]]>
TwitterFacebookLinkedIn